Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease

被引:23
|
作者
Mango, Robert L. [1 ]
Matteson, Eric L. [1 ,2 ]
Crowson, Cynthia S. [1 ,2 ]
Ryu, Jay H. [3 ]
Makol, Ashima [1 ,4 ]
机构
[1] Mayo Clin Coll Med & Sci, Div Rheumatol, Rochester, MN 55905 USA
[2] Mayo Clin Coll Med & Sci, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin Coll Med & Sci, Div Pulm & Crit Care Med, Rochester, MN USA
[4] Mayo Clin, Dept Internal Med, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Systemic sclerosis; Interstitial lung disease; Non-specific interstitial pneumonia; Usual interstitial pneumonia; Mortality modeling; IDIOPATHIC PULMONARY-FIBROSIS; SCLERODERMA LUNG; RISK PREDICTION; STAGING SYSTEM; SURVIVAL; TRIALS; SMOKING; PLACEBO; TRENDS; COHORT;
D O I
10.1007/s00408-018-0126-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The gender, age, and lung physiology (GAP) model, interstitial lung diseases-GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung (SADL) model were compared using a systemic sclerosis-ILD (SSc-ILD) cohort to evaluate which best determined prognosis. The models were applied to a cohort of 179 patients with SSc seen at a tertiary care center within 1 year of ILD diagnosis. Demographics, clinical characteristics, and mortality were recorded. The performance of the models was assessed using standardized mortality ratios (SMR) of observed versus predicted outcomes for calibration and concordance (c)-statistics for discrimination. SSc-ILD patients with usual interstitial pneumonia (31, 17%) had a higher mortality than those with non-specific interstitial pneumonia (147, 83%) (hazard ratio 2.27; 95%CI 1.03-4.97). All 3 models had comparable discrimination (c = 0.72, 0.72, and 0.71, respectively). Regarding calibration, the ILD-GAP model underestimated mortality (SMR 1.50; 95%CI 1.05-2.14). Calibration was acceptable for SADL (SMR 1.00; 95%CI 0.70-1.44) and GAP (SMR 0.90; 95%CI 0.63-1.29). The SADL model underestimated mortality in Stage I ILD. The ILD-GAP model underestimated mortality, and the SADL model underestimated mortality in certain subgroups. However, the GAP model performed well in this cohort, providing the best prognostic information for SSc-ILD.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [31] Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
    Erre, Gian Luca
    Sebastiani, Marco
    Fenu, Maria Antonietta
    Zinellu, Angelo
    Floris, Alberto
    Cavagna, Lorenzo
    Renzoni, Elisabetta
    Manfredi, Andreina
    Passiu, Giuseppe
    Woodman, Richard John
    Mangoni, Arduino Aleksander
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 18
  • [32] Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease
    Morrisroe, Kathleen
    Hansen, Dylan
    Stevens, Wendy
    Ross, Laura
    Sahhar, Joanne
    Ngian, Gene-Siew
    Hill, Catherine L.
    Host, Lauren
    Walker, Jennifer
    Proudman, Susanna
    Nikpour, Mandana
    RHEUMATOLOGY, 2023, 63 (07) : 1874 - 1881
  • [33] The clinical and economic burden of systemic sclerosis related interstitial lung disease
    Morrisroe, Kathleen
    Stevens, Wendy
    Sahhar, Joanne
    Ngian, Gene-Siew
    Ferdowsi, Nava
    Hansen, Dylan
    Patel, Shreeya
    Hill, Catherine L.
    Roddy, Janet
    Walker, Jennifer
    Proudman, Susanna
    Nikpour, Mandana
    RHEUMATOLOGY, 2020, 59 (08) : 1878 - 1888
  • [34] Interstitial lung disease in South Africans with systemic sclerosis
    Ashmore, Philippa
    Tikly, Mohammed
    Wong, Michelle
    Ickinger, Claudia
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (04) : 657 - 662
  • [35] Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease
    Morrisroe, Kathleen
    Hansen, Dylan
    Stevens, Wendy
    Ross, Laura
    Sahhar, Joanne
    Ngian, Gene-Siew
    Hill, Catherine L.
    Host, Lauren
    Walker, Jennifer
    Proudman, Susanna
    Nikpour, Mandana
    RHEUMATOLOGY, 2023, 63 (07) : 1874 - 1881
  • [36] Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease
    Jang, Hye Jin
    Woo, Ala
    Kim, Song Yee
    Yong, Seung Hyun
    Park, Youngmok
    Chung, Kyungsoo
    Lee, Su Hwan
    Leem, Ah Young
    Lee, Sang Hoon
    Kim, Eun Young
    Jung, Ji Ye
    Kang, Young Ae
    Kim, Young Sam
    Park, Moo Suk
    ANNALS OF MEDICINE, 2023, 55 (01) : 663 - 671
  • [37] Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study
    Nakayama, Yoichi
    Nakashima, Ran
    Handa, Tomohiro
    Ohsumi, Akihiro
    Yamada, Yoshito
    Nakajima, Daisuke
    Yutaka, Yojiro
    Tanaka, Satona
    Hamada, Satoshi
    Ikezoe, Kohei
    Tanizawa, Kiminobu
    Shirakashi, Mirei
    Hiwa, Ryosuke
    Tsuji, Hideaki
    Kitagori, Koji
    Akizuki, Shuji
    Yoshifuji, Hajime
    Date, Hiroshi
    Morinobu, Akio
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [38] Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease
    Fischer, Aryeh
    Mistuni, Shigeki
    Curran-Everett, Douglas
    Meehan, Richard T.
    Orich, Sandra K.
    Swigris, Jeffrey J.
    Frankel, Stephen K.
    Cosgrove, Gregory P.
    Lynch, David A.
    Brown, Kevin K.
    CHEST, 2007, 131 (04) : 988 - 992
  • [39] Interstitial lung disease pathology in systemic sclerosis
    Konopka, Kristine E.
    Myers, Jeffrey L.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [40] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364